![](/img/cover-not-exists.png)
FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma
Nair, Abhilasha, Reece, Kelie, Donoghue, Martha B., Yuan, Weishi Vivian, Rodriguez, Lisa, Keegan, Patricia, Pazdur, RichardJournal:
The Oncologist
DOI:
10.1002/onco.13566
Date:
October, 2020
File:
PDF, 658 KB
2020